Lamivudine
A nucleoside analogue.
General information
Lamivudine is a synthetic nucleoside analogue. It acts through inhibition of viral DNA polymerisation. Lamivudine is used for treatment of hepatitis B virus and human immunodeficiency virus 1 infection (NCIt).
Lamivudine on DrugBank
Lamivudine on PubChem
Lamivudine on Wikipedia
Marketed as
3TC; AMILITRAP; ANTIHEB; AVILAM; AVOLAM; COMBIVIR; EPIVIR; FLAMIVUD; GANVIREL; HEPAVIR; HEPITEC; HEPTAVIR; HEPTODIN; HEPTODINE; HEPTOVIR; LAMDA; LAMIBERGEN; LAMIDAC; LAMITEC; LAMIVIR; LAMIVUDINE; ZEFFIX
![Structure image - Lamivudine](/data/images/951.png)
C1C(OC(S1)CO)N2C=CC(=NC2=O)N
Supporting references
Link | Tested on | Impact factor | Notes | Publication date |
---|---|---|---|---|
Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model
Preprint In silico |
in silico | Feb/02/2020 |